当前位置:首页 - 行情中心 - 圣湘生物(688289) - 财务分析

圣湘生物

(688289)

  

流通市值:118.08亿  总市值:118.08亿
流通股本:5.79亿   总股本:5.79亿

圣湘生物(688289)财务分析

净利润 + 每股收益
------
  • 净利润(亿元)
  • 每股收益(元)

    截至2025年半年度实现净利润1.43亿元,每股收益0.28元。

股东权益 + 未分配利润
------
  • 股东权益(亿元)
  • 未分配利润(亿元)

    截至2025年半年度最新股东权益735364.76万元,未分配利润490496.03万元。

总资产 + 负债
------
  • 总资产(亿元)
  • 负债(亿元)

    截至2025年半年度最新总资产951993.32万元,负债216628.56万元。

利润表
报告期2025-06-302025-03-312024-12-312024-09-30
营业总收入868,620,485.26475,488,325.651,458,061,552.961,032,580,636.67
营业总成本702,919,097.81360,282,099.931,278,340,817.64888,194,458.51
其他经营收益
营业利润191,549,753.11101,093,316.29277,776,647.72208,644,648.72
利润总额170,608,533.6799,147,525.58260,611,038.68200,205,817.36
净利润142,740,148.1580,633,918.47226,272,700.73163,076,994.01
每股收益
其他综合收益607,182.97161,778.27-4,533,779.91-85,769,939.35
综合收益总额143,347,331.1280,795,696.74221,738,920.8277,307,054.66
资产负债表
报告期2025-06-302025-03-312024-12-312024-09-30
流动资产:
流动资产合计5,382,425,770.875,776,190,273.855,789,559,824.35,742,694,872.97
非流动资产:
非流动资产合计4,137,507,471.863,908,114,618.512,814,236,319.42,828,499,532.1
资产总计9,519,933,242.739,684,304,892.368,603,796,143.78,571,194,405.07
流动负债:
流动负债合计1,155,569,953.811,301,244,161.97754,803,131.59714,279,677.03
非流动负债:
非流动负债合计1,010,715,687.89950,177,283.84503,207,461.38503,847,469.4
负债合计2,166,285,641.72,251,421,445.811,258,010,592.971,218,127,146.43
所有者权益(或股东权益):
归属于母公司股东权益合计7,254,955,843.647,341,425,327.37,243,225,866.277,238,107,810.77
股东权益合计7,353,647,601.037,432,883,446.557,345,785,550.737,353,067,258.64
负债和股东权益合计9,519,933,242.739,684,304,892.368,603,796,143.78,571,194,405.07
现金流量表
报告期2025-06-302025-03-312024-12-312024-09-30
经营活动产生的现金流量:
经营活动现金流入小计785,729,209.73384,527,693.051,883,267,047.231,304,483,332.1
经营活动现金流出小计928,576,050.75418,344,339.521,608,819,191.121,314,462,196.71
经营活动产生的现金流量净额-142,846,841.02-33,816,646.47274,447,856.11-9,978,864.61
投资活动产生的现金流量:
投资活动现金流入小计715,866,825.58255,981,677.461,545,655,255.361,588,090,222.31
投资活动现金流出小计1,615,358,695.17843,481,221.181,647,576,859.671,559,116,198.93
投资活动产生的现金流量净额-899,491,869.59-587,499,543.72-101,921,604.3128,974,023.38
筹资活动产生的现金流量:
筹资活动现金流入小计949,084,474.13823,302,199.13432,176,986.68429,581,858.96
筹资活动现金流出小计580,155,764.45415,160,798.54299,686,336.98280,295,009.03
筹资活动产生的现金流量净额368,928,709.68408,141,400.59132,490,649.7149,286,849.93
汇率变动对现金及现金等价物的影响1,279,806.12185,714.52-3,296.46-4,560,459.12
现金及现金等价物净增加额-672,130,194.81-212,989,075.08305,013,605.04163,721,549.58
期末现金及现金等价物余额3,804,497,822.114,263,638,941.844,476,628,016.924,335,335,961.46
补充资料:
现金及现金等价物的净增加额-672,130,194.81-305,013,605.04-
最新报告期:2025-09-02
研究机构分析师预测每股收益(元)更新日
2025年2026年2027年
信达证券唐爱金,曹佳琳0.540.700.862025-09-02
中信证券宋硕,陈竹0.630.830.992025-09-01
中泰证券谢木青0.610.760.932025-09-01
华源证券刘闯,林海霖0.520.700.942025-09-01
中金公司俞波,张琎,陈诗雨0.600.77--2025-08-31
TOP↑